BSE Live
Apr 21, 16:01Prev. Close
125.55
Open Price
127.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Key Financial Ratios of Source Natural Foods and Herbal Supplements (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 4.51 | 2.70 | 3.30 | 3.78 | 5.24 | |
| Diluted EPS (Rs.) | 4.51 | 2.70 | 3.30 | 3.78 | 5.24 | |
| Cash EPS (Rs.) | 6.09 | 4.32 | 3.97 | 4.43 | 5.81 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 34.73 | 30.22 | 27.52 | 24.23 | 20.45 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 34.73 | 30.22 | 27.52 | 24.23 | 20.45 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 69.79 | 42.41 | 30.74 | 33.44 | 38.65 | |
| PBDIT/Share (Rs.) | 8.11 | 6.94 | 5.29 | 6.60 | 7.02 | |
| PBIT/Share (Rs.) | 6.54 | 5.32 | 4.62 | 5.96 | 6.45 | |
| PBT/Share (Rs.) | 5.57 | 4.94 | 4.25 | 5.72 | 6.26 | |
| Net Profit/Share (Rs.) | 4.51 | 2.70 | 3.30 | 3.78 | 5.24 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 11.62 | 16.35 | 17.20 | 19.74 | 18.16 | |
| PBIT Margin (%) | 9.36 | 12.53 | 15.01 | 17.81 | 16.68 | |
| PBT Margin (%) | 7.97 | 11.64 | 13.82 | 17.10 | 16.20 | |
| Net Profit Margin (%) | 6.46 | 6.36 | 10.72 | 11.30 | 13.56 | |
| Return on Networth / Equity (%) | 12.98 | 8.92 | 11.97 | 15.59 | 25.63 | |
| Return on Capital Employed (%) | 18.34 | 17.08 | 16.26 | 23.79 | 30.65 | |
| Return on Assets (%) | 8.10 | 7.34 | 9.77 | 12.58 | 19.58 | |
| Total Debt/Equity (X) | 0.33 | 0.00 | 0.00 | 0.00 | 0.07 | |
| Asset Turnover Ratio (%) | 1.51 | 1.20 | 0.96 | 1.18 | 144.45 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 2.03 | 4.98 | 4.91 | 3.76 | 3.01 | |
| Quick Ratio (X) | 1.56 | 3.80 | 3.79 | 2.90 | 2.53 | |
| Inventory Turnover Ratio (X) | 8.66 | 1.28 | 0.78 | 4.47 | 14.33 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 134.17 | 50.89 | 54.33 | 60.32 | 93.49 | |
| EV/Net Operating Revenue (X) | 2.99 | 1.86 | 2.75 | 2.80 | 3.76 | |
| EV/EBITDA (X) | 25.69 | 11.40 | 15.96 | 14.19 | 20.69 | |
| MarketCap/Net Operating Revenue (X) | 2.98 | 2.08 | 2.89 | 2.84 | 3.83 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 5.99 | 2.92 | 3.23 | 3.92 | 7.24 | |
| Price/Net Operating Revenue | 2.98 | 2.08 | 2.89 | 2.84 | 3.83 | |
| Earnings Yield | 0.02 | 0.03 | 0.04 | 0.04 | 0.04 |
24.11.2025
Source Natural Standalone September 2025 Net Sales at Rs 16.95 crore, up 65.3% Y-o-Y
30.05.2025
Source Natural Standalone March 2025 Net Sales at Rs 16.07 crore, up 135.29% Y-o-Y
20.11.2024
Source Natural Standalone September 2024 Net Sales at Rs 10.26 crore, up 48.81% Y-o-Y
19.08.2024
Source Natural Standalone June 2024 Net Sales at Rs 8.16 crore, up 46.15% Y-o-Y
24.11.2025
Source Natural Standalone September 2025 Net Sales at Rs 16.95 crore, up 65.3% Y-o-Y
30.05.2025
Source Natural Standalone March 2025 Net Sales at Rs 16.07 crore, up 135.29% Y-o-Y
20.11.2024
Source Natural Standalone September 2024 Net Sales at Rs 10.26 crore, up 48.81% Y-o-Y
19.08.2024
Source Natural Standalone June 2024 Net Sales at Rs 8.16 crore, up 46.15% Y-o-Y
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth